National Bank of Canada’s Precision BioSciences DTIL Stock Holding History

National Bank of Canada’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,575	Closed	-$41.4K	–	2946
2025 Q3	$41.4K	Buy	7,575 +575	+8%	+$2.75K	﹤0.01%	1983
2025 Q2	$29.4K	Buy	7,000 +2,000	+40%	+$9.87K	﹤0.01%	2081
2025 Q1	$23.6K	Buy	5,000 +1,000	+25%	+$5.09K	﹤0.01%	2052
2024 Q4	$15.2K	Buy	+4,000	New	+$29.2K	﹤0.01%	2233
2023 Q4	–	Sell	-3	Closed	-$33	–	2761
2023 Q3	$33	Buy	+3	New	+$46	﹤0.01%	2739

Other funds holding DTIL

EAM

Empery Asset Management New York $83M AUM

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

National Bank of Canada's DTIL Position: Q4 2025 in Review

National Bank of Canada sold out of Precision BioSciences (DTIL) in Q4 2025, closing a stake of 7,575 shares — an estimated $41.4K sold.

National Bank of Canada first reported a position in DTIL in Q3 2023 and held it in 5 quarters. The position peaked at $41.4K in Q3 2025. 69 funds tracked by Wall St. Rank hold DTIL as of Q4 2025.

National Bank of Canada reported no remaining Precision BioSciences position as of Q4 2025 after selling out during the quarter.
National Bank of Canada sold 7,575 Precision BioSciences shares in Q4 2025, an estimated $41.4K.
National Bank of Canada first reported a position in Precision BioSciences in Q3 2023 and held it in 5 quarters.
National Bank of Canada's Precision BioSciences position peaked at $41.4K in Q3 2025.
69 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.